KEQU — Kewaunee Scientific Income Statement
0.000.00%
Last trade - 00:00- $98.34m
- $157.15m
- $203.76m
- 78
- 84
- 64
- 89
Annual income statement for Kewaunee Scientific, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | 2024 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 148 | 147 | 169 | 219 | 204 |
| Cost of Revenue | |||||
| Gross Profit | 23.4 | 24 | 24.2 | 35.6 | 52.1 |
| Other Operating Expenses | |||||
| Total Operating Expenses | 150 | 149 | 171 | 214 | 185 |
| Operating Profit | -2.35 | -1.32 | -2.61 | 5.36 | 18.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.87 | -2.62 | -2.48 | 4.5 | 13.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.62 | -3.61 | -6 | 1.36 | 19.1 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.69 | -3.67 | -6.13 | 0.738 | 18.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.69 | -3.67 | -6.13 | 0.738 | 18.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.7 | -1.33 | -2.2 | 0.254 | 6.38 |
| Dividends per Share |